NXSTAGE MEDICAL INC's ticker is NXTM and the CUSIP is 67072V103. A total of 128 filers reported holding NXSTAGE MEDICAL INC in Q3 2015. The put-call ratio across all filers is 0.11 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $266,000 | +2.7% | 9,300 | 0.0% | 0.01% | +11.1% |
| Q3 2018 | $259,000 | -14.0% | 9,300 | -13.9% | 0.01% | -18.2% |
| Q2 2018 | $301,000 | +12.3% | 10,800 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $268,000 | +2.3% | 10,800 | 0.0% | 0.01% | 0.0% |
| Q4 2017 | $262,000 | -12.1% | 10,800 | 0.0% | 0.01% | -15.4% |
| Q3 2017 | $298,000 | +16.4% | 10,800 | +5.9% | 0.01% | +18.2% |
| Q2 2017 | $256,000 | -6.6% | 10,200 | 0.0% | 0.01% | -8.3% |
| Q1 2017 | $274,000 | +2.6% | 10,200 | 0.0% | 0.01% | -7.7% |
| Q4 2016 | $267,000 | +4.7% | 10,200 | 0.0% | 0.01% | 0.0% |
| Q3 2016 | $255,000 | +15.4% | 10,200 | 0.0% | 0.01% | +8.3% |
| Q2 2016 | $221,000 | +44.4% | 10,200 | 0.0% | 0.01% | +33.3% |
| Q1 2016 | $153,000 | -21.1% | 10,200 | 0.0% | 0.01% | -25.0% |
| Q4 2015 | $194,000 | +20.5% | 10,200 | 0.0% | 0.01% | +9.1% |
| Q3 2015 | $161,000 | +10.3% | 10,200 | 0.0% | 0.01% | +22.2% |
| Q2 2015 | $146,000 | – | 10,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fort Baker Capital Management LP | 469,319 | $13,089,000 | 7.69% |
| Kite Lake Capital Management (UK) LLP | 1,151,980 | $32,128,000 | 6.64% |
| TIG Advisors, LLC | 4,135,992 | $115,353,000 | 5.45% |
| Tamarack Advisers, LP | 600,000 | $16,734,000 | 4.78% |
| Burren Capital Advisors Ltd | 36,600 | $1,021,000 | 4.58% |
| DAFNA Capital Management LLC | 306,119 | $8,538,000 | 3.51% |
| Moab Capital Partners | 542,725 | $15,137,000 | 3.32% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 3,023,671 | $84,331,000 | 2.32% |
| KOPP INVESTMENT ADVISORS LLC | 98,865 | $2,757,000 | 2.32% |
| HighVista Strategies LLC | 168,403 | $4,697,000 | 2.19% |